ID   PA 16/23
AC   CVCL_W771
DR   Wikidata; Q54937323
RX   PubMed=1320446;
RX   PubMed=8198972;
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C4650; Parotid gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
RX   PubMed=1320446; DOI=10.1002/1097-0142(19920801)70:3<559::AID-CNCR2820700304>3.0.CO;2-2;
RA   Gallo O., Bani D., Toccafondi G., Almerigogna F., Storchi O.F.;
RT   "Characterization of a novel cell line from pleomorphic adenoma of the
RT   parotid gland with myoepithelial phenotype and producing interleukin-6
RT   as an autocrine growth factor.";
RL   Cancer 70:559-568(1992).
//
RX   PubMed=8198972; DOI=10.1038/bjc.1994.209; PMCID=PMC1969413;
RA   Gallo O., Bani D., Giudizi M.G., Biagiotti R., Almerigogna F.,
RA   Toccafondi G., Fini-Storchi O., Romagnani S.;
RT   "Spontaneous in vitro differentiation of a myoepithelial cell line (PA
RT   16/23) from a pleomorphic adenoma of the parotid gland is associated
RT   with reduced production of the autocrine growth factor interleukin
RT   6.";
RL   Br. J. Cancer 69:1065-1071(1994).
//